The Effect of Intravenous Injection Training Based on the ARCS-V Model on Levels of Learning Motivation and Self-Efficacy
10 de julio de 2026 actualizado por: Tubay Bozkurt, Ataturk University
The Effect of Intravenous Injection Training Based on the ARCS-V Model on Nursing Students' Learning Motivation and Self-Efficacy Levels: A Mixed-Methods Study
Intravenous (IV) administration, one of the most fundamental and common practices carried out by nurses, is defined as the administration of medication directly into the circulatory system via a vein.
Intravenous administration is one of the key clinical skills that must be performed using the correct technique.
Supporting students' motivation to learn plays a significant role in the effective acquisition of this skill.
The ARCS-V motivation model, which aims to enhance motivation during the teaching process, comprises the dimensions of attention, relevance, confidence, satisfaction and action.
This study aims to investigate the effect of intravenous administration training based on the ARCS-V model on nursing students' levels of motivation and academic self-efficacy.
The study will be conducted using a mixed-methods design incorporating both a randomised controlled trial and qualitative research methods.
In the study, the experimental group will receive IV administration training structured according to the ARCS-V model, whilst the control group will be taught using the traditional teaching method.
For the collection of quantitative data in this study, the "Demographic Information Form", the "Motivation Scale for Teaching Materials (ÖMMÖ)", the "Academic Self-Efficacy Scale (AÖÖ)" and the "Volition to Learn Scale (VFLS)" will be used.
For the collection of qualitative data in the study, a "Semi-Structured Interview Form" will be used to determine the experiences of students in the experimental group regarding the learning process, and an audio recorder will be used to record the data.
Whilst the quantitative data obtained will be analysed using statistical methods, the qualitative data will be evaluated through content analysis.
It is anticipated that the findings of this research will demonstrate that teaching based on the ARCS-V model contributes to clinical skills training by supporting students' active participation in the learning process, as well as their motivation and will to learn.
Descripción general del estudio
Estado
Estado
Aún no reclutando
Condiciones
Condiciones
Intervención / Tratamiento
Intervención / Tratamiento
Tipo de estudio
Tipo de estudio
Intervencionista
Inscripción (Estimado)
Inscripción
76
Fase
Fase
- No aplica
Contactos y Ubicaciones
Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.
Estudio Contacto
Estudio Contacto
- Nombre: Tubay Bozkurt
- Número de teléfono: +905414694588
- Correo electrónico: bozkurt.tubay@gmail.com
Criterios de participación
Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.
Criterio de elegibilidad
Criterio de elegibilidad
Edades elegibles para estudiar
- Adulto
- Adulto Mayor
Acepta Voluntarios Saludables
Sí
Descripción
Inclusion Criteria:
- To be a student enrolled on the Turkish-language programme at the Faculty of Nursing,
- Be aged 18 or over,
- Have Turkish as your first language,
- Be a first-year student,
- Not be a student on an exchange programme such as Erasmus,
- Be taking the 'Fundamentals of Nursing' course for the first time,
- Not have previously received training in intravenous procedures
- Not to have been absent during the period when research data will be collected, Not to hold a secondary school, foundation year or undergraduate degree in any health-related field
Exclusion Criteria:
- The desire not to take part in any stage of the research or to withdraw from the research
Plan de estudios
Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Otro
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Doble
Número de brazos
2
Armas e Intervenciones
Grupo de participantes/brazoGrupo de participantes/brazo |
Intervención / TratamientoIntervención / Tratamiento |
|---|---|
|
Sin intervención: Traditional Teaching Group
traditional teaching
|
|
|
Experimental: ARCS-V Initiative Group
ARCS-V Model Teaching
|
Teaching Intravenous Injection Techniques Based on the ARCS-V Model
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Teaching Material Motivation Scale (TMMS)
Periodo de tiempo: Assessments will be carried out at three time points. 1st assessment: before the training, 2nd assessment: one week after the training, as the final test, 3rd assessment: one week after the final test
|
Teaching Material Motivation Scale (TMMS): The Teaching Material Motivation Scale (TMMS) was developed based on Keller's (2009) ARCS Model and adapted into Turkish by Dinçer and Doğanay.
The scale consists of 33 items designed to assess motivation towards teaching materials and covers four dimensions: attention, relevance, confidence and satisfaction.
The original scale comprises 36 items.
The Cronbach's alpha coefficients for the scale have been reported as 0.96 overall; 0.89 for the attention dimension; 0.81 for the relevance dimension; 0.90 for the trust dimension; and 0.92 for the satisfaction dimension.
Assessment is carried out using a 5-point Likert-type scale, with a total score range of 33 to 165; an increase in score is interpreted as an increase in motivation levels.
The scale's score ranges are classified from very low (33-37) to very high (161-165).
|
Assessments will be carried out at three time points. 1st assessment: before the training, 2nd assessment: one week after the training, as the final test, 3rd assessment: one week after the final test
|
|
Academic Self-Efficacy Scale (AÖÖ)
Periodo de tiempo: Assessments will be carried out at three time points. 1st assessment: before the training, 2nd assessment: one week after the training, as the final test, 3rd assessment: one week after the final test
|
Academic Self-Efficacy Scale (AÖÖ): Adapted into Turkish by Yılmaz, Gürçay and Ekici (2007).
Developed as a four-point Likert-type scale, it has a unidimensional structure and consists of seven items.
Scores on the scale range from 7 to 28, with higher scores indicating a higher level of academic self-efficacy.
In the Turkish adaptation study, the scale's Cronbach's alpha internal consistency coefficient was reported as 0.79.
|
Assessments will be carried out at three time points. 1st assessment: before the training, 2nd assessment: one week after the training, as the final test, 3rd assessment: one week after the final test
|
Colaboradores e Investigadores
Aquí es donde encontrará personas y organizaciones involucradas en este estudio.
Patrocinador
Patrocinador
Publicaciones y enlaces útiles
La persona responsable de ingresar información sobre el estudio proporciona voluntariamente estas publicaciones. Estos pueden ser sobre cualquier cosa relacionada con el estudio.
Fechas de registro del estudio
Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.
Fechas importantes del estudio
Inicio del estudio (Estimado)
Inicio del estudio
15 de julio de 2026
Finalización primaria (Estimado)
Finalización primaria
15 de septiembre de 2026
Finalización del estudio (Estimado)
Finalización del estudio
26 de diciembre de 2027
Fechas de registro del estudio
Enviado por primera vez
Enviado por primera vez
1 de julio de 2026
Primero enviado que cumplió con los criterios de control de calidad
Primero enviado que cumplió con los criterios de control de calidad
7 de julio de 2026
Publicado por primera vez (Actual)
Publicado por primera vez
9 de julio de 2026
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización publicada
13 de julio de 2026
Última actualización enviada que cumplió con los criterios de control de calidad
Última actualización enviada que cumplió con los criterios de control de calidad
10 de julio de 2026
Última verificación
Última verificación
1 de julio de 2026
Más información
Términos relacionados con este estudio
Palabras clave
Otros números de identificación del estudio
Otros números de identificación del estudio
- B.30.2.ATA.0.01.TB
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
NO
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
No
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
No
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .